Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles

Genomic screening has unique challenges which makes it difficult to easily implement on a wide scale. If the costs, benefits and tradeoffs of investing in genomic screening are not evaluated properly, there is a risk of wasting finite healthcare resources and also causing avoidable harm. If healthca...

Full description

Saved in:
Bibliographic Details
Published in:BMC health services research 2019-11, Vol.19 (1), p.823-8, Article 823
Main Authors: Dombrádi, Viktor, Pitini, Erica, van El, Carla G, Jani, Anant, Cornel, Martina, Villari, Paolo, Gray, Muir, Bíró, Klára
Format: Article
Language:English
Subjects:
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - prevention & control
Chronic disease
Chronic Disease - prevention & control
Chronic diseases
Chronic illnesses
Debate
Decision Making
Delivery of Health Care - methods
Early Diagnosis
Female
Genetic Predisposition to Disease - prevention & control
Genetic testing
Genetic Testing - standards
Genomics
Genomics - methods
Genomics - standards
Health care reform
Health Personnel
Health screening
Health services
Humans
Medical personnel
Mutation - genetics
Ovarian cancer
Prevention
Retirement benefits
Screening
Value-based healthcare
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233
cites cdi_FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233
container_end_page 8
container_issue 1
container_start_page 823
container_title BMC health services research
container_volume 19
creator Dombrádi, Viktor
Pitini, Erica
van El, Carla G
Jani, Anant
Cornel, Martina
Villari, Paolo
Gray, Muir
Bíró, Klára
description Genomic screening has unique challenges which makes it difficult to easily implement on a wide scale. If the costs, benefits and tradeoffs of investing in genomic screening are not evaluated properly, there is a risk of wasting finite healthcare resources and also causing avoidable harm. If healthcare professionals - including policy makers, payers and providers - wish to incorporate genomic screening into healthcare while minimizing waste, maximizing benefits, and considering results that matter to patients, using the principles of triple value (allocative, technical, and personal value) could help them to evaluate tough decisions and tradeoffs. Allocative value focuses on the optimal distribution of limited healthcare resources to maximize the health benefits to the entire population while also accounting for all the costs of care delivery. Technical value ensures that for any given condition, the right intervention is chosen and delivered in the right way. Various methods (e.g. ACCE, HTA, and Wilson and Jungner screening criteria) exist that can help identify appropriate genomic applications. Personal value incorporates preference based informed decision making to ensure that patients are informed about the benefits and harms of the choices available to them and to ensure they make choices based on their values and preferences. Using triple value principles can help healthcare professionals make reasoned and tough judgements about benefits and tradeoffs when they are exploring the role genomic screening for chronic diseases could play in improving the health of their patients and populations.
doi_str_mv 10.1186/s12913-019-4703-z
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_75a768ed6e834aea8b2fc902eee2a09f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A607362027</galeid><doaj_id>oai_doaj_org_article_75a768ed6e834aea8b2fc902eee2a09f</doaj_id><sourcerecordid>A607362027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233</originalsourceid><addsrcrecordid>eNptkstu1TAQhiMEoqXwAGxQJDbdpPh-YYFUVUArVWIDbC3HmaQ-SuyDnVTQp6_DKW0PIC9sz8z_jS9_Vb3G6ARjJd5lTDSmDcK6YRLR5uZJdYiZJI3Qgj59tD6oXuS8QQhLReTz6oBiiTFT9LCavttxgaa1Gbp6gBAn7-rsEkDwYXhfw8_tGFNZ_pus-5hqd5ViKNHOZyiMXC95Tc3Jb0eor1d4vS16t-7zy-pZb8cMr-7mo-rbp49fz86byy-fL85OLxvHBZobhiVRrkes1UpT4NxhKS1HpGs5ByY4xZ2WCJTmvGMYdKss10hQ1uJWEkqPqosdt4t2Y0r_yaZfJlpvfgdiGoxNs3cjGMmtFAo6AYoyC1a1pHcaEQAgFum-sD7sWNulnaBzEOZkxz3ofib4KzPEayMU04TqAji-A6T4Y4E8m8lnB-NoA8QlG0IxQ5RKtZ777V-lm7ikUJ7KEMYJEoor_lA12HIBH_pY-roVak4FklQQRGSpOvlPVRkdlG-MAXpf4nsCvBO4FHNO0N_fESOz-s3s_GaK38zqN3NTNG8eP8694o_B6C0wFtDK</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452068585</pqid></control><display><type>article</type><title>Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles</title><source>Publicly Available Content Database</source><source>ABI/INFORM Global</source><source>PubMed Central</source><creator>Dombrádi, Viktor ; Pitini, Erica ; van El, Carla G ; Jani, Anant ; Cornel, Martina ; Villari, Paolo ; Gray, Muir ; Bíró, Klára</creator><creatorcontrib>Dombrádi, Viktor ; Pitini, Erica ; van El, Carla G ; Jani, Anant ; Cornel, Martina ; Villari, Paolo ; Gray, Muir ; Bíró, Klára</creatorcontrib><description>Genomic screening has unique challenges which makes it difficult to easily implement on a wide scale. If the costs, benefits and tradeoffs of investing in genomic screening are not evaluated properly, there is a risk of wasting finite healthcare resources and also causing avoidable harm. If healthcare professionals - including policy makers, payers and providers - wish to incorporate genomic screening into healthcare while minimizing waste, maximizing benefits, and considering results that matter to patients, using the principles of triple value (allocative, technical, and personal value) could help them to evaluate tough decisions and tradeoffs. Allocative value focuses on the optimal distribution of limited healthcare resources to maximize the health benefits to the entire population while also accounting for all the costs of care delivery. Technical value ensures that for any given condition, the right intervention is chosen and delivered in the right way. Various methods (e.g. ACCE, HTA, and Wilson and Jungner screening criteria) exist that can help identify appropriate genomic applications. Personal value incorporates preference based informed decision making to ensure that patients are informed about the benefits and harms of the choices available to them and to ensure they make choices based on their values and preferences. Using triple value principles can help healthcare professionals make reasoned and tough judgements about benefits and tradeoffs when they are exploring the role genomic screening for chronic diseases could play in improving the health of their patients and populations.</description><identifier>ISSN: 1472-6963</identifier><identifier>EISSN: 1472-6963</identifier><identifier>DOI: 10.1186/s12913-019-4703-z</identifier><identifier>PMID: 31711483</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Breast cancer ; Breast Neoplasms - genetics ; Breast Neoplasms - prevention &amp; control ; Chronic disease ; Chronic Disease - prevention &amp; control ; Chronic diseases ; Chronic illnesses ; Debate ; Decision Making ; Delivery of Health Care - methods ; Early Diagnosis ; Female ; Genetic Predisposition to Disease - prevention &amp; control ; Genetic testing ; Genetic Testing - standards ; Genomics ; Genomics - methods ; Genomics - standards ; Health care reform ; Health Personnel ; Health screening ; Health services ; Humans ; Medical personnel ; Mutation - genetics ; Ovarian cancer ; Prevention ; Retirement benefits ; Screening ; Value-based healthcare</subject><ispartof>BMC health services research, 2019-11, Vol.19 (1), p.823-8, Article 823</ispartof><rights>COPYRIGHT 2019 BioMed Central Ltd.</rights><rights>2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s). 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233</citedby><cites>FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233</cites><orcidid>0000-0001-5108-9154</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849239/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2452068585?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11688,25753,27924,27925,36060,36061,37012,37013,44363,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31711483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dombrádi, Viktor</creatorcontrib><creatorcontrib>Pitini, Erica</creatorcontrib><creatorcontrib>van El, Carla G</creatorcontrib><creatorcontrib>Jani, Anant</creatorcontrib><creatorcontrib>Cornel, Martina</creatorcontrib><creatorcontrib>Villari, Paolo</creatorcontrib><creatorcontrib>Gray, Muir</creatorcontrib><creatorcontrib>Bíró, Klára</creatorcontrib><title>Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles</title><title>BMC health services research</title><addtitle>BMC Health Serv Res</addtitle><description>Genomic screening has unique challenges which makes it difficult to easily implement on a wide scale. If the costs, benefits and tradeoffs of investing in genomic screening are not evaluated properly, there is a risk of wasting finite healthcare resources and also causing avoidable harm. If healthcare professionals - including policy makers, payers and providers - wish to incorporate genomic screening into healthcare while minimizing waste, maximizing benefits, and considering results that matter to patients, using the principles of triple value (allocative, technical, and personal value) could help them to evaluate tough decisions and tradeoffs. Allocative value focuses on the optimal distribution of limited healthcare resources to maximize the health benefits to the entire population while also accounting for all the costs of care delivery. Technical value ensures that for any given condition, the right intervention is chosen and delivered in the right way. Various methods (e.g. ACCE, HTA, and Wilson and Jungner screening criteria) exist that can help identify appropriate genomic applications. Personal value incorporates preference based informed decision making to ensure that patients are informed about the benefits and harms of the choices available to them and to ensure they make choices based on their values and preferences. Using triple value principles can help healthcare professionals make reasoned and tough judgements about benefits and tradeoffs when they are exploring the role genomic screening for chronic diseases could play in improving the health of their patients and populations.</description><subject>Breast cancer</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - prevention &amp; control</subject><subject>Chronic disease</subject><subject>Chronic Disease - prevention &amp; control</subject><subject>Chronic diseases</subject><subject>Chronic illnesses</subject><subject>Debate</subject><subject>Decision Making</subject><subject>Delivery of Health Care - methods</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Genetic Predisposition to Disease - prevention &amp; control</subject><subject>Genetic testing</subject><subject>Genetic Testing - standards</subject><subject>Genomics</subject><subject>Genomics - methods</subject><subject>Genomics - standards</subject><subject>Health care reform</subject><subject>Health Personnel</subject><subject>Health screening</subject><subject>Health services</subject><subject>Humans</subject><subject>Medical personnel</subject><subject>Mutation - genetics</subject><subject>Ovarian cancer</subject><subject>Prevention</subject><subject>Retirement benefits</subject><subject>Screening</subject><subject>Value-based healthcare</subject><issn>1472-6963</issn><issn>1472-6963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkstu1TAQhiMEoqXwAGxQJDbdpPh-YYFUVUArVWIDbC3HmaQ-SuyDnVTQp6_DKW0PIC9sz8z_jS9_Vb3G6ARjJd5lTDSmDcK6YRLR5uZJdYiZJI3Qgj59tD6oXuS8QQhLReTz6oBiiTFT9LCavttxgaa1Gbp6gBAn7-rsEkDwYXhfw8_tGFNZ_pus-5hqd5ViKNHOZyiMXC95Tc3Jb0eor1d4vS16t-7zy-pZb8cMr-7mo-rbp49fz86byy-fL85OLxvHBZobhiVRrkes1UpT4NxhKS1HpGs5ByY4xZ2WCJTmvGMYdKss10hQ1uJWEkqPqosdt4t2Y0r_yaZfJlpvfgdiGoxNs3cjGMmtFAo6AYoyC1a1pHcaEQAgFum-sD7sWNulnaBzEOZkxz3ofib4KzPEayMU04TqAji-A6T4Y4E8m8lnB-NoA8QlG0IxQ5RKtZ777V-lm7ikUJ7KEMYJEoor_lA12HIBH_pY-roVak4FklQQRGSpOvlPVRkdlG-MAXpf4nsCvBO4FHNO0N_fESOz-s3s_GaK38zqN3NTNG8eP8694o_B6C0wFtDK</recordid><startdate>20191111</startdate><enddate>20191111</enddate><creator>Dombrádi, Viktor</creator><creator>Pitini, Erica</creator><creator>van El, Carla G</creator><creator>Jani, Anant</creator><creator>Cornel, Martina</creator><creator>Villari, Paolo</creator><creator>Gray, Muir</creator><creator>Bíró, Klára</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5108-9154</orcidid></search><sort><creationdate>20191111</creationdate><title>Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles</title><author>Dombrádi, Viktor ; Pitini, Erica ; van El, Carla G ; Jani, Anant ; Cornel, Martina ; Villari, Paolo ; Gray, Muir ; Bíró, Klára</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Breast cancer</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - prevention &amp; control</topic><topic>Chronic disease</topic><topic>Chronic Disease - prevention &amp; control</topic><topic>Chronic diseases</topic><topic>Chronic illnesses</topic><topic>Debate</topic><topic>Decision Making</topic><topic>Delivery of Health Care - methods</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Genetic Predisposition to Disease - prevention &amp; control</topic><topic>Genetic testing</topic><topic>Genetic Testing - standards</topic><topic>Genomics</topic><topic>Genomics - methods</topic><topic>Genomics - standards</topic><topic>Health care reform</topic><topic>Health Personnel</topic><topic>Health screening</topic><topic>Health services</topic><topic>Humans</topic><topic>Medical personnel</topic><topic>Mutation - genetics</topic><topic>Ovarian cancer</topic><topic>Prevention</topic><topic>Retirement benefits</topic><topic>Screening</topic><topic>Value-based healthcare</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dombrádi, Viktor</creatorcontrib><creatorcontrib>Pitini, Erica</creatorcontrib><creatorcontrib>van El, Carla G</creatorcontrib><creatorcontrib>Jani, Anant</creatorcontrib><creatorcontrib>Cornel, Martina</creatorcontrib><creatorcontrib>Villari, Paolo</creatorcontrib><creatorcontrib>Gray, Muir</creatorcontrib><creatorcontrib>Bíró, Klára</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC health services research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dombrádi, Viktor</au><au>Pitini, Erica</au><au>van El, Carla G</au><au>Jani, Anant</au><au>Cornel, Martina</au><au>Villari, Paolo</au><au>Gray, Muir</au><au>Bíró, Klára</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles</atitle><jtitle>BMC health services research</jtitle><addtitle>BMC Health Serv Res</addtitle><date>2019-11-11</date><risdate>2019</risdate><volume>19</volume><issue>1</issue><spage>823</spage><epage>8</epage><pages>823-8</pages><artnum>823</artnum><issn>1472-6963</issn><eissn>1472-6963</eissn><abstract>Genomic screening has unique challenges which makes it difficult to easily implement on a wide scale. If the costs, benefits and tradeoffs of investing in genomic screening are not evaluated properly, there is a risk of wasting finite healthcare resources and also causing avoidable harm. If healthcare professionals - including policy makers, payers and providers - wish to incorporate genomic screening into healthcare while minimizing waste, maximizing benefits, and considering results that matter to patients, using the principles of triple value (allocative, technical, and personal value) could help them to evaluate tough decisions and tradeoffs. Allocative value focuses on the optimal distribution of limited healthcare resources to maximize the health benefits to the entire population while also accounting for all the costs of care delivery. Technical value ensures that for any given condition, the right intervention is chosen and delivered in the right way. Various methods (e.g. ACCE, HTA, and Wilson and Jungner screening criteria) exist that can help identify appropriate genomic applications. Personal value incorporates preference based informed decision making to ensure that patients are informed about the benefits and harms of the choices available to them and to ensure they make choices based on their values and preferences. Using triple value principles can help healthcare professionals make reasoned and tough judgements about benefits and tradeoffs when they are exploring the role genomic screening for chronic diseases could play in improving the health of their patients and populations.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>31711483</pmid><doi>10.1186/s12913-019-4703-z</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5108-9154</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1472-6963
ispartof BMC health services research, 2019-11, Vol.19 (1), p.823-8, Article 823
issn 1472-6963
1472-6963
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_75a768ed6e834aea8b2fc902eee2a09f
source Publicly Available Content Database; ABI/INFORM Global; PubMed Central
subjects Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - prevention & control
Chronic disease
Chronic Disease - prevention & control
Chronic diseases
Chronic illnesses
Debate
Decision Making
Delivery of Health Care - methods
Early Diagnosis
Female
Genetic Predisposition to Disease - prevention & control
Genetic testing
Genetic Testing - standards
Genomics
Genomics - methods
Genomics - standards
Health care reform
Health Personnel
Health screening
Health services
Humans
Medical personnel
Mutation - genetics
Ovarian cancer
Prevention
Retirement benefits
Screening
Value-based healthcare
title Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A41%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Value-based%20genomic%20screening:%20exploring%20genomic%20screening%20for%20chronic%20diseases%20using%20triple%20value%20principles&rft.jtitle=BMC%20health%20services%20research&rft.au=Dombr%C3%A1di,%20Viktor&rft.date=2019-11-11&rft.volume=19&rft.issue=1&rft.spage=823&rft.epage=8&rft.pages=823-8&rft.artnum=823&rft.issn=1472-6963&rft.eissn=1472-6963&rft_id=info:doi/10.1186/s12913-019-4703-z&rft_dat=%3Cgale_doaj_%3EA607362027%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c560t-41728cf04b9893e55c177a502db55e46531d970e8955d41e9b8a590634b1b7233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2452068585&rft_id=info:pmid/31711483&rft_galeid=A607362027&rfr_iscdi=true